Dianthus Therapeutics | MGTA - Créances Commerciales





Créances Commerciales Changement Date
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Avita Medical AUD 9.11M 2.26M 2025-12
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
IQVIA Holdings USD 3.39B 12M 2026-06
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 17M 54M 2026-06
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Organon & Co USD 1.49B 108M 2026-06
Ovoca Bio EUR 53K 14K 2025-12
Pharma Mar EUR 58.06M 6.87M 2026-06
Qiagen NV USD 398.35M 1.73M 2026-06
Revvity USD 709.18M 17.79M 2026-06
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.13B 49.9M 2026-06
Xeris Pharmaceuticals USD 56.29M 5.24M 2026-03
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03